An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections - Related Studies

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections

This study has been completed.

Study NCT00001757. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Mycoses

2	Additional conditions recognized in this trial
		Infection

3	Interventions listed in this trial
		Voriconazole

4	More general drug interventions related to this trial
		Anti-Infective Agents
		Antifungal Agents
		Pharmacologic Actions
		Therapeutic Uses

5	Sponsors listed in this trial
		National Institute of Allergy and Infectious Diseases (NIAID)